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In the course of a structural analysis of the a-chain of elongation factor 1 from Artemia sulina cysts, we 
present four amino acid sequences comprising together half of the polypeptide chain. A comparison of 
these sequences with the primary structure of elongation factor EF-Tu from Escherichia coli reveals aclear 
correspondence b tween the eukaryotic and prokaryotic protein throughout their polypeptide chains. The 
results upport abasic conservation f the structure of the aminoacyl-tRNA carrying enzyme in evolution. 
The occurrence, in the eukaryotic factor, of several c-trimethyllysine residues, is remarkable. 
Eukaryotic elongation factor Primary structure Sequence homology 
1. INTRODUCTION 
The elongation factor which binds aminoacyl- 
tRNA to the ribosome plays a crucial role in pro- 
tein biosynthesis [l]. The bacterial factor EF-Tu, 
as found in Escherichia coli, has a i&value of 
43000 and consists of a single polypeptide chain 
with a length of 393 amino acid residues. Its 
primary structure has been elucidated [2-41, and 
studies concerning its three-dimensional structure 
are in progress [5-71. 
regions in EF-Tu from E. coli. The sequence of 
one of these peptides matches exactly with an 
amino acid sequence deduced from copy DNA of 
mRNA, isolated from cysts of A. salina. 
2. MATERIALS AND METHODS 
The eukaryotic elongation factor EF-1 occurs in 
a high-M, and low-M, form. In the brine shrimp 
Artemia salina, the high-i&& form is found 
predominantly in dormant cysts [8], and consists 
of a complex of three different polypeptide chains 
[9]. One of these chains, EF-la, binds aminoacyl 
tRNA and is identical to the low-M, form, which 
is present as such in free-swimming nauplii [9]. In 
A. salina, this chain has an Mr of -53 000 and cor- 
responds to bacterial EF-Tu. In contrast to the 
bacterial factor, it is a basic protein with an 
isoelectric point of 8.5. 
Elongation factor EF-la from A. salina was 
isolated from cysts, essentially as in [9]; the two- 
phase separation step with polyethyleneglycol, 
however, was omitted and instead a 30-80% am- 
monium sulphate cut of the postribosomal super- 
natant was used for the carboxymethyl-Sephadex 
C50 chromatography. 
2.1. Limited digestion with trypsin 
Here we present the amino acid sequences of 4 
polypeptide fragments, obtained from EF-lcu from 
A. salina, which clearly are homologous to distinct 
Typically, 6.5 mg EF-la, in 10 ml Tris-HCI 
(pH 7.5), 100 mM KCI, 1 mM magnesium acetate, 
0.1 mM EDTA, 10 mM 2-mercaptoethanol and 
25% (v/v) glycerol, was digested with 15Opg 
TPCK-treated trypsin (Worthington) for 2 h at 
30°C. Under these conditions, a 45000 M, tryptic 
fragment was generated in high yield, like in the 
case of EF-Tu from E. co/i [lO,l 11. This fragment 
was purified by gel filtration over Sephadex G75 
superfine, in 1% (v/v) HCOOH and 20 mM 
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2-mercaptoethanol, and lyophilized. The yield was 
3.4 mg. 
2.2. Isolation and purification procedures of the 
other peptides 
Peptides were purified by gel filtration over 
Sephadex G75 superfine, in 0.5% (v/v) 
trifluoroacetic acid. Most peptides proved to be 
soluble in this solvent, which at the same time per- 
mits an absorbance recording at 220 nm. When 
necessary, a second purification step was ac- 
complished by reversed-phase high-performance li- 
quid chromatography on octadecyl @ Bondapak 
C18, Waters) or cyanopropyl (Zorbax CN) col- 
umns. Two systems were used: (A) a linear gra- 
dient from 0.2% (v/v) trifluoroacetic acid to 0.1% 
trifluoroacetic acid and 45% (v/v) propan-l-01, in 
6” 
Fig.1. Elution profile of the BrCN-generated peptides 
from S-pyridylethyl-EF-lcu, soluble in 0.5% (v/v) 
trifluoroacetic acid. The column of Sephadex G75 
superfine (1.6 cm x 110 cm) was eluted at -4 ml/h. 
Fig.2. Elution profile of BrCN-peptide III, digested with 
hydroxylamine. The desalted peptide was chromato- 
graphed on a column of Sephadex G75 superfine (1.0 x 
110 cm) at -2 ml/h. Fractions of 20 drops were 
collected. Peak A contains the original peptide; peak B 
Fractions of 40 drops were collected. a mixture of the two large digestion products. 
90 min (1 .O ml/min); (B) a procedure adapted 
from that of R. van der Zee (Groningen) - it con- 
sists of a gradient from 0.1% (v/v) trifluoroacetic 
acid, 10% (v/v) 2-methoxyethanol, 3% (v/v) 
butan-l-01 to 0.04% (v/v) trifluoroacetic acid, 
10% (v/v) 2-methoxyethanol, 45% (v/v) ethanol, 
15% (v/v) butan-l-01, in 90 min (1 .O ml/min) (see 
also [12]). 
2.3. BrCN-generated peptides 
EF-lcu was treated in 8 M urea, with either 
4-vinyl pyridine (redistilled) [ 131 or iodoacetic acid 
[14] in order to block its cysteine residues. Subse- 
quently, the dialyzed and lyophilized modified 
protein was dissolved in 70% (v/v) HCOOH, con- 
taining 1% 2-mercaptoethanol, and digested with 3 
times its weight of BrCN, for 24 h in the dark 
3.0 - 
2.5 - 
2.” - 
I.5 - 
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under nitrogen at room temperature. After 
rotatory evaporation and lyophilization, most pep- 
tides were obtained in pure form by gel filtration 
(fig. 1). 
peptide:enzyme weight ratio of -25 : 1. Peptides 
were purified as described above. 
2.5. Treatment with hydroxylamine 
2.4. ~~t~acony~at~o~ and di~esfio~ with trypsin; 
digestion with c~~t~~pain 
S-Pyridylethyl EF-lcu and BrCN-generated pep- 
tides were citraconyIated [15] and digested with 
trypsin 1161. A first separation was obtained by gel 
filtration over Sephadex G75 superfine (section 
2.2); cuts from the eluate were subsequently 
chromatographed using system A (section 2.2). 
Hydrolysis of BrCN-peptide III at its Asn-Gly 
bonds was performed according to 1171. The pep- 
tide mixture was desalted 1181, chromatographed 
over Sephadex G75 superfine (section 2.2; fig.2) 
and further purified by high-performance liquid 
chromatography using system B (section 2.2; 
fig.3). 
2.6, Amino acid analysis 
Alternatively, BrCN-generated peptides were This was performed with a Beckman 
further degraded by clostripain (Boehringer), in Multichrom M amino acid analyzer. Hydrolysis 
0.1 M sodium phosphate (pH 8.0), 0.5 mM CaClz was either in 6 M HCI containing 0.05~~ 
and 7 mM dithiothreitol, at 30°C for 2 h with a 2-mercaptoethanol for 20 h at llO”C, or in pro- 
. 
I I I 1 I 1 
50 40 30 20 10 
FRACTION NUMBER 
A220 
0:1 
0.05 
Fig.3. Elutian profile of hydroxylamine-generated peptides, obtained from BrCN-peptide III GBondapak Cl&column). 
Peak B from fig.2 was rechromatographed in system B (section 2.2). The elution profile shown was obtained with -l/30 
of the total sample; peak 1 contains the peptide starting at Gly-325; peak 2 the peptide starting at His-261. 
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pionic acid/l2 M HCI (1: 1, v/v) for 15 min at 
160°C [19]. 
2.1. Manual sequencing 
This was according to [20] with N,N-dimethyl- 
aminoazobenzene 4-isothiocyanate. 
2.8. Liquid phase sequencing 
This was performed with a Beckman Model 
890 C sequencer (equipped with a Balzers oil filter) 
with a 0.25 M Quadrol program. Polybrene [21] 
was added when peptides to be sequenced were 
540 amino acid residues. To decrease their 
solubility in organic solvents, peptides were, when 
necessary, modified with 3-isothiocyano-I S- 
naphthalene disulfonic acid [22] or, in the case of 
BrCN-generated peptides, with arginine at their C- 
terminal homoserine lactone [23]. 
PTH amino acids were identified by high- 
performance liquid chromatography [24] and by 
amino acid analysis after back hydrolysis [25,26]. 
c-Trimethyllysine, found at three positions in the 
peptides shown (see fig.4), could be identified by 
means of an authentic sample of this amino acid. 
3. RESULTS AND DISCUSSION 
At least 4 regions of EF-lcx from A. salina have 
sequences, which are remarkably similar to certain 
regions of EF-Tu from E. coli (fig.4). 
Sequence A represents the first 45 residues of a 
45000 M, tryptic fragment of EF-la, obtained 
under limited digestion conditions (section 2.4). 
The homology with the first 45 residues of the cor- 
responding 37000 M, fragment of EF-Tu from E. 
coli is obvious. After this observation was made, 
we learned that a comparable homology was found 
between the first 12 residues of a similar tryptic 
fragment of rabbit reticulocyte EF-lcx and the 
37000 M, bacterial fragment [27]. 
*** 
A A.s. GLY-ILE-THR-ILE-ASP-ILE-ALA-LEU-TRP-LYS-PHE-GLU-THR-ALA-SER-TYR-TYR-VAL-THR-ILE-ILE-ASP- 
.a 0.0 0 cl 0 0 cl 0.0 0 Cl 0 0. 
E.c. ARG-GLY-ILE-THR-ILE-ASN-THR-SER-HIS-VAL-GLU-TIR-ASP-THR-PRO-THR-ARG-HIS-TYR-ALA-HIS-VAL-ASP- 
60 70 80 
A.s. ALA-PRO-GLY-HIS-ARG-ASP-PHE-ILE-LYS-ASN-MET-ILE-THR-GLY-THR-SER-GLX-ALA-ASP-SER-ALA-VAL-LEU- 
. . . .o o......o 0 0 .o .o. 
E.c. CYS-PRO-GLY-HIS-ALA-ASP-TYR-VAL-LYS-ASN-MET-ILE-THR-GLY-ALA-ALA-GLN-MET-ASP-GLY-ALA-ILE-LEU- 
90 100 
B A.s. GLU-HIS-ALA-LEU-LEU-ALA-TYR-THR-LEU-GLY-VAL-LYS- X -LEU-ILE-VAL-GLY-VAL-ASN-LYS- 
. . .o 0 0.. 0.. 0.. 
E.c. ARG-GLU-HIS-ILE-LEU-LEU-GLY-ARG-GLN-VAL-GLY-VAL-PRO-TYR-ILE-ILE-VAL-PHE-LEU-ASN-LYS- 
120 130 
*** 
C A.s. LYS-GLU-GLY-LYS-ALA-ASP-GLY-LYS-THR-LEU-LEU-ASP-ALA-LEU-ASP-ALA-ILE-LEU-PRO-PRO-SER-ARG- 
0.. .o 0 0 0 0 0 0 0.0 0 0. 
E.c. ALA-LE"-GL"-GLY-ASP-ALA-GLU-TRP-GLU-ALA-LYS-ILE-LEU-GLU-LE~-ALA-GLY-PHE-LEU-ASP-S~R-~R-I~E- 
180 190 
A.s. PRO- THR-GLU-LYS-PRO-ILE-ARG-LEU-PRO-LEU-GLN-ASP-V~-TYR-LYS-ILE-GLY-GLY- 
. "..0 0. 0 . 
E.C. PRO-GL"-PRO-GLU-ARG-ALA-~~R-ASP-LYS-PRO-PHE-L~U-LEU-P~O-IL~-G~U-ASP-V~L-P~E-SER-I~E-S~R-G~Y- 
200 210 220 
A.s. ILE-GLY-THR-VAL-PRO-VAL-GLY-ARG- 
. 
E.c. A;G-GLY-TiR-V:L-"AL-THR-G;Y-A;G- 
230 
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D A.s. ILE-VAL-THR-PHE-ALA-PRO-ALA-ASN-ILE-THR-~R-~U-V~-LYS-SER-V~-GLU-~T-HIS-HIS-GLU-SER- 
0. 0 0 0 0 0 0 
E.c. GLU-ILE-VAL-GLY-ILE-LYS-GLU-THR-GLN-LYS-SER-THR- -CYS-TF;R-GLY-Vk-GkJ-;T-PHE-A;G-L&k- 
250 260 
*** 
A.S. LEU-GLU-GLU-ALA-SER-PRO-GLY-ASP-ASN-VAL-GLY-PHE-ASN-VAL-LYS-ASN-VAL-SER-VAL-LYS-GLU-LEU-ARG- 
E.c. L~U-A~P-G:U-G~Y-~G-~-G~Y-G~U-A~N-V~L-G~Y-V~-LRU-L~U-AORG-GLY-I~-LYS-ARG-G~U-G~U-I~-GLU- 
270 280 
A.S. ARG-GLY-TYR-VAL-ALA-SER-ASP-SER-LYS-ASN-ASN-PRO-ALA- X -GLY-GLN-GLU-ASP-PHE-PHE-ALA-GLU-VAL- 
. . . 0 0 0 0 0 0 0 . . 
E.c. ARG-GLY-GLN-VAL-LEU-ALA-LYS-PRO-GLY-THR-ILE-LYS-PRO-HIS-THR-LYS- -P:E-GLU-SER-GLU-VAL- 
290 300 
A.S. ILE-VAL-LEU-ASN- -GLY-PRO-GLY-GLX- -ILE-SER-ASN-GLY-TYR-THR-PRO-VAL-LEU-ASP- 
0 . 0 0 . . 0 . 0 0 
E.c. TYR-I~E-L~U-SER-LYS-ASP-G~U-GLY-GLY-ARG-HIS-THR-PRO-PHE-PHE-LYS-GLY-TYR-ARG-PRO-GLN-PHE-mR- 
310 320 330 
A.s. CYS-HIS-THR-ALA-HIS-ILE-ALB-CYS-LYS-PHE-ALA- X -ILE-LYS-GLU-LYS- X -ASP-ARGARG-THR-GLY-LYS- 
0 0.0 0 0 0 0 0 0 0 0 0 0 0. 
E.c. PHE-ARG-THR-THR-ASP-VAL-THR-GLY-THR-ILE-GLU-LEU-PRO-GLU-GLY-VAL-GLU-MET-VAL-MET-PRO-GLY-~P- 
340 350 
A.s. THR-THR-GLU-ALA-GLU-PRO-LYS-PHE-ILE-LYS-SER-GLY-ASP- 
0 0 0 0 0 0 l 0 0 
E.C. ASN-ILE-LYS-MET-VAL-VAL-THR-LEU-ILR-HIS-PRO-ILE-ALA- 
360 
*** 
LYS = E-trimethyllysine 
Fig.4. Amino acid sequences of polypeptide fragments of EF-lcu from A. sulina. The sequences have been aligned with 
the amino acid sequence of EF-Tu from E. cd. The numbering of this protein is used throughout. (A) Tryptic 45000 
Mr fragment. The sequence was determined to step 40 (pos. 98). An overlap was found with a BrCN-generated peptide 
(VI in fig.l), starting at pos. 92 (E. coli EF-Tu numbering), of which 12 residues were determined. (B) A peptide, 
obtained from S-pyridylethyl EF-la after citraconylation and digestion with trypsin, having a length of -35 amino acid 
residues. The first 20 residues are given. (C) A region deduced from 3 peptides: (a) BrCN-peptide V (fig.l) was 
citraconylated and digested with trypsin. Gel filtration yielded a peptide comprising pos. 178-211 of which the first 
18 residues were determined; (b) Peptide 178-230, obtained from the tryptic digest of the citraconylated protein, was 
subdigested with trypsin (after decitraconylation). Peptide 186-219 was isolated, and sequenced completely; (c) Peptide 
212-230 was obtained from the tryptic digest of the citraconylated protein and sequenced completely. (D) A region 
deduced from two BrCN-generated peptides: (a) BrCN-peptide 244-260 (XI in fig.1) was sequenced completely. (b) 
BrCN-peptide starting at pos. 261 (III in fig.1). This large peptide was sequenced to step 32 (pos. 292). Then, the intact 
peptide was subdigested with (1) trypsin after citraconylation, or (2) with clostripain. A large peptide starting at pos. 
289 (and, in the former case, also a peptide starting at pos. 288) could be isolated. The first 47 residues were determined. 
Moreover, the intact peptide was treated with hydroxylamine (171, and the peptide starting at Gly-325 was isolated (fig.2 
and 3). The first 43 residues were determined. The overlap between both BrCN-peptides was provided by a peptide 
comprising pos. 257-279, which was obtained from a clostripain digest of the protein. The first 13 residues of this 
peptide were determined: (0) identical residues; (0) possible single base replacements. Only a limited number of gaps 
has been introduced to fit both sequences. 
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The total result clearly points to an evolutionary 
relationship between the prokaryotic and 
eukaryotic elongation factor, and conservation of 
their spatial structure as well. The first 180 residues 
of the bacterial fragment comprise the so-called 
tight domain [28], which includes sequences 
homologous to the regions B and C of EF-1~ from 
A. salina. 
Region D is composed from the two consecutive 
BrCN-peptides XI and III, and shows a clear 
similarity with the region starting at pos. 261 in 
EF-Tu from E. coli. This region contains an amino 
acid sequence which is identical to that deduced 
from a cDNA sequence. This cDNA was synthesiz- 
ed using mRNA for EF-lc~ from A. salina as a 
template [29]. 
Interestingly, the protein is post-translationally 
methylated in at least 3 sites (fig.4), with the for- 
mation of exclusively f-trimethyllysine (E- 
monomethyllysine or f-dimethyllysine were found 
to be absent at these positions). The significance of 
this modification is not known. Methylation of 
EF-lcu from the fungus Mucor was reported in 
[301. 
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